WallStreetZenWallStreetZen
Analyst Ranking
Top 3%
#126 out of 4241 analysts
Average Return
+14.94%
Win Rate
55%61 out of 111
Risk vs Reward
Poor
Good

Vamil Divan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cabaletta Bio IncCABA
+702.34%$1.28$10.27
2022-05-25 -
2023-05-24
Strong Buy
Cabaletta Bio IncCABA
+313.27%$1.96$8.10
2022-03-18 -
2023-03-17
Strong Buy
Revance Therapeutics IncRVNC
+170.20%$13.22$35.72
2022-05-11 -
2023-05-11
Strong Buy
Axsome Therapeutics IncAXSM
+98.88%$35.84$71.28
2022-05-03 -
2023-05-02
Strong Buy
Biohaven Pharmaceutical Holding Co LtdBHVN1
+98.67%$70.47$140.00
2021-05-11 -
2022-05-10
Strong Buy

Vamil Divan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Revance Therapeutics IncRVNC
3Strong Buy$35.00+17.17%Maintains
4 days ago
Ani Pharmaceuticals IncANIP
2Strong Buy$59.00+19.22%Maintains
a month ago
Chinook Therapeutics IncKDNY
2Strong Buy$35.00+45.89%Maintains
a month ago
Travere Therapeutics IncTVTX
2Strong Buy$23.00+37.97%Maintains
a month ago
Abbvie IncABBV
15Strong Buy$171.00+23.75%Maintains
a month ago
Scynexis IncSCYX
2Strong Buy$9.00+226.09%Maintains
2 months ago
Calliditas Therapeutics AbCALT
1Hold$18.00+5.26%Initiates Coverage On
3 months ago
Aerovate Therapeutics IncAVTE
1Strong Buy$36.00+127.27%Initiates Coverage On
3 months ago
Johnson & JohnsonJNJ
6Hold$161.00+0.62%Initiates Coverage On
3 months ago
Sage Therapeutics IncSAGE
5Hold$45.00-24.42%Maintains
4 months ago
Satsuma Pharmaceuticals IncSTSA
5Hold$2.00+81.82%Downgrades
7 months ago
Acadia Pharmaceuticals IncACAD
7Hold$19.00-23.14%Maintains
10 months ago
Karuna Therapeutics IncKRTX
6Strong Buy$276.00+21.25%Maintains
10 months ago
Neurocrine Biosciences IncNBIX
5Hold$98.00+4.94%Maintains
10 months ago
Alkermes PLCALKS
7Strong Buy$34.00+9.22%Maintains
10 months ago
Cabaletta Bio IncCABA
3Strong Buy$10.00N/AMaintains
a year ago
Axsome Therapeutics IncAXSM
3Strong Buy$49.00N/AMaintains
a year ago
Eli Lilly & CoLLY
12Strong Buy$356.00N/AMaintains
a year ago
Xeris Biopharma Holdings IncXERS
1Strong Buy$6.00N/AMaintains
a year ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
9Strong Buy$154.00N/AMaintains
a year ago
Pfizer IncPFE
11Hold$56.00N/AMaintains
a year ago
Relmada Therapeutics IncRLMD
1Strong Buy$50.00N/AInitiates Coverage On
2 years ago
Evolus IncEOLS
4Strong Buy$15.00N/AUpgrades
2 years ago
Allergan PLCAGN
9Hold$155.00N/AMaintains
4 years ago
Teva Pharmaceutical Industries LtdTEVA
10Hold$20.00N/AMaintains
4 years ago
Galapagos NvGLPG
3BuyN/AN/AUpgrades
4 years ago
Portola Pharmaceuticals IncPTLA
6Hold$30.00N/AMaintains
5 years ago
Alder Biopharmaceuticals IncALDR
2Hold$17.00N/AMaintains
5 years ago
Merck & Co IncMRK
5Buy$81.00N/AMaintains
5 years ago
Corvus Pharmaceuticals IncCRVS
3Buy$15.00N/AAssumes
5 years ago
Aimmune Therapeutics IncAIMT
3Buy$40.00N/AMaintains
5 years ago
Bristol Myers Squibb CoBMY
2Hold$61.00N/AMaintains
5 years ago
Allena Pharmaceuticals IncALNAQ
2Buy$21.00N/AMaintains
5 years ago
Esperion Therapeutics IncESPR
2Buy$103.00N/AInitiates Coverage On
5 years ago
Myokardia IncMYOK
1Buy$55.00N/AMaintains
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.